AstraZeneca

The initiative, driven by Cancer Research and Statistic Foundation and supported by AstraZeneca, Pfizer and Roche, and lab partner…

GlobalData’s report reveals that CGT market for GI disorders, as a standalone therapy area, is expected to increase from $47…

In addition, AstraZeneca is launching a new joint venture with BioKangtai, to develop, manufacture, and commercialise innovative…

EsoBiotec will become a wholly owned subsidiary of AstraZeneca, with operations in Belgium

The event will bring together industry leaders to discuss the evolving role of contract manufacturing in global pharma

Insights from experts in the field highlight the urgent need for improved diagnostic tools and targeted therapies to address this…

GlobalData’s latest report reveals that market growth will primarily be driven by the uptake of new monoclonal antibodies (mAbs),…

These US investments are the first of a series of important steps to help deliver AstraZeneca’s ambition to achieve $80 billion in…

This collaboration aims to focus on education, early detection and spreading awareness among healthcare professionals, parents,…

With a novel CD40L-targeting mechanism and favourable efficacy outcomes, this therapy has the potential to challenge established…